BD Needle Kit for Powered Driver Recall Issued

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on September 9, 2026 and geographically references United States. The FDA classifies this as a Class I recall, with the stated reason "After placement of intraosseous (IO) needle sets, used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases, users may experience difficulty/inability to remove obturator, due to it locking to the needle hub, due to out-of-tolerance dimensions and IFU unclarity, which may result in new needle placement, which may result in delayed therapy", distributed us: ma, fl, ia, sc, il, ny, ut, nj, id, in, pa, ca, tx, oh, mo, va, md, nc, al, mn, co, ky, la, nv, ok, ms, az, mi, ga, ar, ks, tn. ous: ca, sg. FDA recall classes run from I (reasonable probability of serious harm) to III (unlikely to cause harm), so the class number is the fastest way to gauge severity here. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.